Zobrazeno 1 - 10 of 24 pro vyhledávání: '"A M Galløe"'
1
Akademický článek
Stent thrombosis is the primary cause of ST-segment elevation myocardial infarction following coronary stent implantation: a five year follow-up of the SORT OUT II study.
Autor: Søren Lund Kristensen, Anders M Galløe, Leif Thuesen, Henning Kelbæk, Per Thayssen, Ole Havndrup, Peter Riis Hansen, Niels Bligaard, Kari Saunamäki, Anders Junker, Jens Aarøe, Ulrik Abildgaard, Jørgen L Jeppesen
Publikováno v: PLoS ONE, Vol 9, Iss 11, p e113399 (2014)
The widespread use of coronary stents has exposed a growing population to the risk of stent thrombosis, but the importance in terms of risk of ST-segment elevation myocardial infarctions (STEMIs) remains unclear.We studied five years follow-up data f
Externí odkaz: https://doaj.org/article/9877e0dcd79f4c0581cfd93c41f1314d
Zobrazit plný text záznamu
2
10-Year Clinical Outcome After Randomization to Treatment by Sirolimus- or Paclitaxel-Eluting Coronary Stents
Autor: Anders M. Galløe, Henning Kelbæk, Leif Thuesen, Henrik S. Hansen, Jan Ravkilde, Peter R. Hansen, Evald H. Christiansen, Ulrik Abildgaard, Ghita Stephansen, Jens F. Lassen, Thomas Engstrøm, Jan Skov Jensen, Jørgen L. Jeppesen, Niels Bligaard, Per Thayssen, Jens Aarøe, Kari Saunamäki, Anders Junker, Hans H. Tilsted, Jan S. Jensen, Hans E. Bøtker, Søren Galatius, Carsten T. Larsen, Steen D. Kristensen, Lars R. Krusell, Steen Z. Abildstrøm, Michael Meng, Lisette Okkels
Publikováno v: Galløe, A M, Kelbæk, H, Thuesen, L, Hansen, H S, Ravkilde, J, Hansen, P R, Christiansen, E H, Abildgaard, U, Stephansen, G, Lassen, J F, Engstrøm, T, Jensen, J S, Jeppesen, J L, Bligaard, N & SORT OUT II Investigators 2017, ' 10-Year Clinical Outcome After Randomization to Treatment by Sirolimus- or Paclitaxel-Eluting Coronary Stents ', Journal of the American College of Cardiology, vol. 69, no. 6, pp. 616-624 . https://doi.org/10.1016/j.jacc.2016.11.055
Galløe, A M, Kelbæk, H, Thuesen, L, Hansen, H S, Ravkilde, J, Hansen, P R, Christiansen, E H, Abildgaard, U, Stephansen, G B, Lassen, J F, Engstrøm, T, Jensen, J S, Jeppesen, J L, Bligaard, N & SORT OUT II Investigators 2017, ' 10-Year Clinical Outcome After Randomization to Treatment by Sirolimus- or Paclitaxel-Eluting Coronary Stents ', Journal of the American College of Cardiology, vol. 69, no. 6, pp. 616-624 . https://doi.org/10.1016/j.jacc.2016.11.055
BACKGROUND: First-generation drug-eluting coronary stents (DES) were introduced in 2003 to 2004, and their use resulted in a considerable reduction in the development of in-stent restenosis at the cost of an increased risk of late stent thromboses.OB
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::817665c8bd37f309907a57a497e7aeba
https://vbn.aau.dk/da/publications/5740607f-5d0e-4644-9747-2bafaf5efc8f
Zobrazit plný text záznamu
3
Dosage dependent hormonal counter regulation to combination therapy in patients with left ventricular dysfunction
Autor: P. Dalgaard, K. Larsen, A. M. Galløe, K. Skagen, E. K. Frandsen, Niels Juel Christensen, S. L. Nielsen, Peter Bie
Publikováno v: Galløe, A M, Skagen, K, Christensen, N J, Nielsen, S L, Frandsen, E K, Bie, P, Dalgaard, P & Larsen, K 2006, ' Dosage dependent hormonal counter regulation to combination therapy in patients with left ventricular dysfunction. ', Journal of Clinical Pharmacy and Therapeutics, vol. 31, no. 2, pp. 139-147 .
Udgivelsesdato: april 2006 The present study attempts to assess the efficacy combination therapy for heart failure. Genuine dose-response studies on combination therapy are not available and published studies involved adding one drug on top of 'usual
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::663e56fc11707c0aba738c2bbe189234
https://doi.org/10.1111/j.1365-2710.2006.00606.x
Zobrazit plný text záznamu
4
Similar five-year outcome with paclitaxel- and sirolimus-eluting coronary stents
Autor: Niels, Bligaard, Leif, Thuesen, Kari, Saunamäki, Per, Thayssen, Jens, Aarøe, Peter Riis, Hansen, Jens Flensted, Lassen, Ghita, Stephansen, Jørgen L, Jeppesen, Anders Michael, Galløe, Anders M, Galløe
Publikováno v: Bligaard, N, Thuesen, L, Saunamäki, K, Thayssen, P, Aarøe, J, Hansen, P R, Lassen, J F, Stephansen, G, Jeppesen, J L, Galløe, A M & SORT OUT II Investigators 2014, ' Similar five-year outcome with paclitaxel-and sirolimus-eluting coronary stents ', Scandinavian Cardiovascular Journal, vol. 48, no. 3, pp. 148-155 . https://doi.org/10.3109/14017431.2014.883461
Bligaard, N, Thuesen, L, Saunamäki, K, Thayssen, P, Aarøe, J, Hansen, P R, Lassen, J F, Stephansen, G, Jeppesen, J, Galløe, A M & for the SORT OUT II investigators 2014, ' Similar five-year outcome with paclitaxel-and sirolimus-eluting coronary stents ', Scandinavian Cardiovascular Journal, vol. 48, no. 3, pp. 148-155 . https://doi.org/10.3109/14017431.2014.883461
Bligaard, N, Thuesen, L, Saunamäki, K, Thayssen, P, Aarøe, J, Hansen, P R, Lassen, J F, Stephansen, G, Jeppesen, J, Galløe, A M & for the SORT OUT II investigators 2014, ' Similar five-year outcome with paclitaxel-and sirolimus-eluting coronary stents ', Scandinavian Cardiovascular Journal . https://doi.org/10.3109/14017431.2014.883461
OBJECTIVE: Millions of patients were treated with the sirolimus-eluting Cypher™ and the paclitaxel-eluting Taxus™ coronary stents with potential late-occurring increase in event rates. Therefore, the long-term outcome follow-up is of major clinic
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35adac4167296977e0c3b4e8c0167c03
https://pubmed.ncbi.nlm.nih.gov/24548278
Zobrazit plný text záznamu
5
Comparison of paclitaxel- and sirolimus-eluting stents in everyday clinical practice: the SORT OUT II randomized trial
Autor: Anders M. Galløe, Leif Thuesen, Henning Kelbæk, Per Thayssen, Klaus Rasmussen, Peter R. Hansen, Niels Bligaard, Kari Saunamäki, Anders Junker, Jens Aarøe, Ulrik Abildgaard, Jan Ravkilde, Thomas Engstrøm, Jan S. Jensen, Henning R. Andersen, Hans E. Bøtker, Søren Galatius, Steen D. Kristensen, Jan K. Madsen, Lars R. Krusell, Steen Z. Abildstrøm, Ghita B. Stephansen, Jens F. Lassen, for the SORT OUT II Investigators
Publikováno v: Galløe, A M, Thuesen, L, Kelbaek, H, Thayssen, P, Rasmussen, K, P. R., H, Bligaard, N, Saunamäki, K, Junker, A, Aarøe, J, Abildgaard, U, Ravkilde, J, Engstrøm, T, Jensen, J S, Andersen, H R, Bøtker, H E, Galatius, S, Kristensen, S D, Madsen, J K, Krusell, L R, Abildstrøm, S Z, Stephansen, G B & Lassen, J F 2008, ' Comparison of paclitaxel-and sirolimus-eluting stents in everyday clinical practice: the SORT OUT II randomized trial. ', JAMA: The Journal of the American Medical Association, vol. 299, no. 4, pp. 409-16 . https://doi.org/10.1001/jama.299.4.409
Galløe, A M, Thuesen, L, Kelbaek, H, Thayssen, P, Rasmussen, K, Hansen, P R, Bligaard, N, Saunamäki, K, Junker, A, Aarøe, J, Abildgaard, U, Ravkilde, J, Engstrøm, T, Jensen, J S, Andersen, H R, Bøtker, H E, Galatius, S, Kristensen, S D, Madsen, J K, Krusell, L R, Abildstrøm, S Z, Stephansen, G B, Lassen, J F & SORT OUT II Investigators 2008, ' Comparison of paclitaxel-and sirolimus-eluting stents in everyday clinical practice : the SORT OUT II randomized trial ', JAMA-Journal of the American Medical Association, vol. 299, no. 4, pp. 409-416 . https://doi.org/10.1001/jama.299.4.409
ContextApproval of drug-eluting coronary stents was based on results of relatively small trials of selected patients; however, in routine practice, stents are used in a broader spectrum of patients.ObjectiveTo compare the first 2 commercially availab
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f1ca501e4f30144b27dcce7a99b34d2
https://pure.au.dk/portal/da/publications/comparison-of-paclitaxel-and-sirolimuseluting-stents-in-everyday-clinical-practice-the-sort-out-ii-randomized-trial(49c50ae0-35f6-11dd-9465-000ea68e967b).html
Zobrazit plný text záznamu
6
[Severe obstructive lung disease. The effect of the calcium antagonist isradipine on working capacity, pulmonary function, morbidity and survival]
Autor: J R, Petersen, A M, Galløe, N A, Graudal, M, Galløe
Publikováno v: Ugeskrift for laeger. 155(34)
Several studies have reported beneficial haemodynamic effects of calcium antagonists in the treatment of patients with chronic obstructive pulmonary disease (COPD) and pulmonary hypertension. Such effects include a decrease in pulmonary vascular resi
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::aa0a376071417aacbd56b9be53a6fb80
https://pubmed.ncbi.nlm.nih.gov/8212369
Zobrazit plný text záznamu
8
[Contrast echocardiography. Basic principles and clinical applications]
Autor: P R, Hansen, U, Abildgaard, A M, Galløe, T N, Jacobsen, E, Kassis, K, Lindvig
Publikováno v: Ugeskrift for laeger. 162(44)
Recent advances in ultrasound technology and intravenous contrast agents have made it possible for contrast echocardiography to move from bench to bedside. Ultrasound contrast agents enhance endocardial border delineation and the Doppler signal, whic
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::c48b41f6b1374f6361f291b4d8e59b6e
https://pubmed.ncbi.nlm.nih.gov/11094566
Zobrazit plný text záznamu
10
Aminoglycosides: single or multiple daily dosing? A meta-analysis on efficacy and safety
Autor: Hanne Rolighed Christensen, A M Galløe, Niels Graudal, Jens P. Kampmann
Publikováno v: European journal of clinical pharmacology. 48(1)
A number of randomised studies indicate that a single high dose of aminoglycoside every 24 h may be more efficient and less toxic than the same dose divided into multiple daily doses. In the meta-analysis of 16 studies described here, which included
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8f1b9bccfeef0365ff2ffe39d2140ec
https://pubmed.ncbi.nlm.nih.gov/7621846
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje